OMID HLDGS Stock Price, News & Analysis
Company Description
OMID HLDGS (OTC Link: OMID) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $2.0M.
OMID stock has gained 184.2% over the past year. Shares last traded at $0.0594.
This page provides a comprehensive overview of OMID stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
OMID HLDGS (OMID) stock last traded at $0.0594. Over the past 12 months, the stock has gained 184.2%. At a market capitalization of $2.0M, OMID is classified as a micro-cap stock with approximately 96.3M shares outstanding.
Latest News
OMID HLDGS has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all OMID news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in OMID HLDGS (OMID) currently stands at 12.3 thousand shares, down 0.1% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 262%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for OMID HLDGS (OMID) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
OMID Company Profile & Sector Positioning
OMID HLDGS (OMID) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing OMID often look at related companies in the same sector, including Endexx Corp (EDXC), Craftport Cannabis Corp (BHHKF), Radient Tech (RDDTF), Isracann Biosciences (ISCNF), and Cannapharmarx (CPMD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OMID's relative position within its industry.